Fond’Action Grant obteined by the Regenerative Medicine Technologies Lab
The “Fond’Action contre le cancer” supports a project of the Regenerative Medicine Technologies Lab. The team of prof. Matteo Moretti, in collaboration with the team of prof. Francesco Bertoni (at IOR), will work on the development of a 3D high throughput platform reproducing lymphoma disease in the bone marrow. The platform will be used to…
